| Product NDC: | 55390-059 |
| Proprietary Name: | Orphenadrine citrate |
| Non Proprietary Name: | Orphenadrine citrate |
| Active Ingredient(s): | 60 mg/2mL & nbsp; Orphenadrine citrate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-059 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040463 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030428 |
| Package NDC: | 55390-059-10 |
| Package Description: | 10 VIAL in 1 BOX (55390-059-10) > 2 mL in 1 VIAL |
| NDC Code | 55390-059-10 |
| Proprietary Name | Orphenadrine citrate |
| Package Description | 10 VIAL in 1 BOX (55390-059-10) > 2 mL in 1 VIAL |
| Product NDC | 55390-059 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Orphenadrine citrate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20030428 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | ORPHENADRINE CITRATE |
| Strength Number | 60 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |